论文部分内容阅读
自1956年Harrington提出原发性血小板减少性紫癜(ITP)是一种免疫性疾病后,20多年的研究证明在患者血清中存在抗血小板抗体,并能直接测定血小板表面相关抗体。本文旨在从临床角度观察患者的免疫功能。
Since Harrington’s presentation of idiopathic thrombocytopenic purpura (ITP) in 1956 as an autoimmune disease, more than 20 years of research have demonstrated the presence of anti-platelet antibodies in the serum of patients and the direct determination of platelet surface-associated antibodies. This article aims to observe the patient’s immune function from a clinical perspective.